Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
JCO Oncology Practice|January 5, 2023
Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the OvaryCourtney A Penn, Ronald D AlvarezGynecologic Oncology|May 25, 2024
Trends in estimated PARP inhibitor eligibility and benefit among US epithelial ovarian cancer patientsErica V Carballo, Kenneth H Kim, Courtney A PennTrends in Immunology|January 24, 2025
Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatmentsRomi Gupta, Raj Kumar, Courtney A Penn, et al.JAMA Network Open|December 9, 2020
Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United StatesCourtney A Penn, Melissa S Wong, Christine S WalshCurrent Treatment Options in Oncology|January 3, 2024
Sentinel Lymph Node Evaluation in Early-Stage Vulvar CancerCourtney A Penn, Mali K Schneiter, Catherine H WatsonGynecologic Oncology|December 1, 2018
Preoperatively predicting non-home discharge after surgery for gynecologic malignancyCourtney A Penn, Neil S Kamdar, Daniel M Morgan, et al.Cell Death & Disease|July 21, 2023
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPEPraveen Guruvaiah, Suresh Chava, Chiao-Wang Sun, et al.Gynecologic Oncology Reports|June 2, 2022
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease statusCourtney A Penn, Erica V Carballo, Christine S Walsh, et al.Obstetrics and Gynecology|September 9, 2016
Timing of and Reasons for Unplanned 30-Day Readmission After Hysterectomy for Benign DiseaseCourtney A Penn, Daniel M Morgan, Laurel W Rice, et al.Fertility and Sterility|June 16, 2019
Association of serum androgens and coronary artery calcium scores in womenCourtney A Penn, Jessica Chan, Clementina Mesaros, et al.Pageof 2